---
figid: PMC10929194__ijbsv20p1947g001
figtitle: Canonical pathways downstream of KRAS mutations
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10929194
filename: ijbsv20p1947g001.jpg
figlink: /pmc/articles/PMC10929194/figure/F1
number: F1
caption: 'Canonical pathways downstream of KRAS mutations. KRAS mutation leads to
  permanent activation of the KRAS protein, activating several downstream pathways
  both directly (represented by components in green) and indirectly (represented by
  components in yellow) regulated by KRAS. Five pathways are directly under the control
  of KRAS: 1) the RAF-MEK-ERK pathway, 2) the RalGDS pathway, 3) the TGF pathway,
  4) the PI3K-AKT-mTOR pathway, and 5) the JNK pathway. The JNK pathway is named after
  the final kinases (ERK, JNK, and p38) of the RAF-MEK-ERK pathway. The KRAS:1 indirectly
  regulates five pathways: 1) the p38-MAPK pathway, 2) the NF-kB pathway, 3) the Hippo-YAP
  pathway, 4) the Notch pathway, and 5) the Hedgehog pathway. (→direct regulated;
  --> indirectly regulated)'
papertitle: Impact of KRAS mutation on the tumor microenvironment in colorectal cancer
reftext: Yiru Zhou, et al. Int J Biol Sci. 2024;20(5).
year: '2024'
doi: 10.7150/ijbs.88779
journal_title: International Journal of Biological Sciences
journal_nlm_ta: Int J Biol Sci
publisher_name: Ivyspring International Publisher
keywords: Colorectal cancer | KRAS mutation | Tumor microenvironment | Immunotherapy
automl_pathway: 0.9097322
figid_alias: PMC10929194__F1
figtype: Figure
redirect_from: /figures/PMC10929194__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10929194__ijbsv20p1947g001.html
  '@type': Dataset
  description: 'Canonical pathways downstream of KRAS mutations. KRAS mutation leads
    to permanent activation of the KRAS protein, activating several downstream pathways
    both directly (represented by components in green) and indirectly (represented
    by components in yellow) regulated by KRAS. Five pathways are directly under the
    control of KRAS: 1) the RAF-MEK-ERK pathway, 2) the RalGDS pathway, 3) the TGF
    pathway, 4) the PI3K-AKT-mTOR pathway, and 5) the JNK pathway. The JNK pathway
    is named after the final kinases (ERK, JNK, and p38) of the RAF-MEK-ERK pathway.
    The KRAS:1 indirectly regulates five pathways: 1) the p38-MAPK pathway, 2) the
    NF-kB pathway, 3) the Hippo-YAP pathway, 4) the Notch pathway, and 5) the Hedgehog
    pathway. (→direct regulated; --> indirectly regulated)'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK3
  - MAPK1
  - MAPK6
  - MAPK12
  - MAPK7
  - MAPK8
  - MAPK9
  - MAPK10
  - KRAS
  - NRAS
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - IL6
  - MTG1
  - RALA
  - RALB
  - OTUB2
  - YAP1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - CREBBP
  - EIF4E
  - OPN1LW
  - PAG1
  - PCBP4
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - NFKB1
  - TBP
  - GTF2B
  - JUN
  - JUNB
  - JUND
  - DHH
  - IHH
  - SHH
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - MEK
  - GDP
  - GTP
  - TBP
  - cancer
  - colorectal cancer
---
